vs

Side-by-side financial comparison of Nano Labs Ltd (NA) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

cbdMD, Inc. is the larger business by last-quarter revenue ($5.0M vs $2.7M, roughly 1.9× Nano Labs Ltd). Nano Labs Ltd runs the higher net margin — 754.5% vs -5.6%, a 760.1% gap on every dollar of revenue. cbdMD, Inc. produced more free cash flow last quarter ($-977.3K vs $-8.4M).

Weebit Nano is a public semiconductor IP company founded in Israel in 2015 and headquartered in Hod HaSharon, Israel. The company develops Resistive Random-Access Memory technologies. Resistive Random-Access Memory is a specialized form of non-volatile memory (NVM) for the semiconductor industry. The company's products are targeted at a broad range of NVM markets where persistence, performance, and endurance are all required. ReRAM technology can be integrated in electronic devices like weara...

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

NA vs YCBD — Head-to-Head

Bigger by revenue
YCBD
YCBD
1.9× larger
YCBD
$5.0M
$2.7M
NA
Higher net margin
NA
NA
760.1% more per $
NA
754.5%
-5.6%
YCBD
More free cash flow
YCBD
YCBD
$7.4M more FCF
YCBD
$-977.3K
$-8.4M
NA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NA
NA
YCBD
YCBD
Revenue
$2.7M
$5.0M
Net Profit
$20.3M
$-283.1K
Gross Margin
59.8%
Operating Margin
-5.7%
Net Margin
754.5%
-5.6%
Revenue YoY
-1.9%
Net Profit YoY
-1975.7%
EPS (diluted)
$1.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NA
NA
YCBD
YCBD
Q4 25
$2.7M
$5.0M
Q3 25
$4.7M
Q2 25
$1.2M
$4.6M
Q1 25
$4.7M
Q4 24
$5.1M
Q3 24
$4.6M
Q2 24
$3.5M
$5.2M
Q1 24
$4.4M
Net Profit
NA
NA
YCBD
YCBD
Q4 25
$20.3M
$-283.1K
Q3 25
$-680.0K
Q2 25
$-985.5K
$-895.3K
Q1 25
$-480.8K
Q4 24
$15.1K
Q3 24
$-152.8K
Q2 24
$-8.0M
$459.7K
Q1 24
$-3.0M
Gross Margin
NA
NA
YCBD
YCBD
Q4 25
59.8%
Q3 25
58.8%
Q2 25
61.5%
Q1 25
62.3%
Q4 24
66.5%
Q3 24
53.9%
Q2 24
0.1%
65.8%
Q1 24
59.0%
Operating Margin
NA
NA
YCBD
YCBD
Q4 25
-5.7%
Q3 25
-14.5%
Q2 25
-459.2%
-19.6%
Q1 25
-10.2%
Q4 24
-1.7%
Q3 24
-6.9%
Q2 24
-237.2%
-7.4%
Q1 24
-35.4%
Net Margin
NA
NA
YCBD
YCBD
Q4 25
754.5%
-5.6%
Q3 25
-14.4%
Q2 25
-85.2%
-19.4%
Q1 25
-10.1%
Q4 24
0.3%
Q3 24
-3.4%
Q2 24
-231.3%
8.9%
Q1 24
-68.8%
EPS (diluted)
NA
NA
YCBD
YCBD
Q4 25
$1.03
Q3 25
Q2 25
$-0.06
Q1 25
Q4 24
Q3 24
Q2 24
$-0.12
$-0.15
Q1 24
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NA
NA
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$4.9M
$3.4M
Total DebtLower is stronger
$24.5M
Stockholders' EquityBook value
$106.5M
$9.0M
Total Assets
$159.3M
$11.8M
Debt / EquityLower = less leverage
0.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NA
NA
YCBD
YCBD
Q4 25
$4.9M
$3.4M
Q3 25
$2.3M
Q2 25
$50.8M
$1.1M
Q1 25
$1.8M
Q4 24
$2.0M
Q3 24
$2.5M
Q2 24
$3.3M
$2.4M
Q1 24
$2.1M
Total Debt
NA
NA
YCBD
YCBD
Q4 25
$24.5M
Q3 25
Q2 25
$24.8M
Q1 25
Q4 24
Q3 24
Q2 24
$22.5M
Q1 24
Stockholders' Equity
NA
NA
YCBD
YCBD
Q4 25
$106.5M
$9.0M
Q3 25
$7.2M
Q2 25
$86.8M
$6.1M
Q1 25
$665.8K
Q4 24
$1.8M
Q3 24
$2.0M
Q2 24
$-5.1M
$3.0M
Q1 24
$3.1M
Total Assets
NA
NA
YCBD
YCBD
Q4 25
$159.3M
$11.8M
Q3 25
$10.4M
Q2 25
$206.4M
$9.9M
Q1 25
$10.9M
Q4 24
$11.5M
Q3 24
$10.6M
Q2 24
$51.2M
$13.8M
Q1 24
$14.6M
Debt / Equity
NA
NA
YCBD
YCBD
Q4 25
0.23×
Q3 25
Q2 25
0.29×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NA
NA
YCBD
YCBD
Operating Cash FlowLast quarter
$-8.3M
$-812.5K
Free Cash FlowOCF − Capex
$-8.4M
$-977.3K
FCF MarginFCF / Revenue
-312.3%
-19.5%
Capex IntensityCapex / Revenue
2.9%
3.3%
Cash ConversionOCF / Net Profit
-0.41×
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NA
NA
YCBD
YCBD
Q4 25
$-8.3M
$-812.5K
Q3 25
$-240.7K
Q2 25
$-7.1M
$-704.2K
Q1 25
$-189.5K
Q4 24
$-317.9K
Q3 24
$167.4K
Q2 24
$-10.8M
$289.8K
Q1 24
$-704.1K
Free Cash Flow
NA
NA
YCBD
YCBD
Q4 25
$-8.4M
$-977.3K
Q3 25
$-243.6K
Q2 25
$-7.2M
$-705.7K
Q1 25
$-205.0K
Q4 24
$-482.3K
Q3 24
$157.4K
Q2 24
$-15.4M
Q1 24
$-708.7K
FCF Margin
NA
NA
YCBD
YCBD
Q4 25
-312.3%
-19.5%
Q3 25
-5.2%
Q2 25
-620.3%
-15.3%
Q1 25
-4.3%
Q4 24
-9.4%
Q3 24
3.5%
Q2 24
-443.4%
Q1 24
-16.2%
Capex Intensity
NA
NA
YCBD
YCBD
Q4 25
2.9%
3.3%
Q3 25
0.1%
Q2 25
7.2%
0.0%
Q1 25
0.3%
Q4 24
3.2%
Q3 24
0.2%
Q2 24
133.1%
0.0%
Q1 24
0.1%
Cash Conversion
NA
NA
YCBD
YCBD
Q4 25
-0.41×
Q3 25
Q2 25
Q1 25
Q4 24
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NA
NA

Segment breakdown not available.

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons